Ianalumab plus Eltrombopag in Immune Thrombocytopenia

Journal:
The New England Journal of Medicine
Published:
DOI:
10.1056/nejmoa2515168
Affiliations:
31
Authors:
26
Institutions Authors Share
Novartis, Switzerland
3.000000
0.12
Agostino Gemelli University Polyclinic, Italy
1.000000
0.04
University of Pennsylvania (Penn), United States of America (USA)
1.000000
0.04
Nanfang Hospital, China
1.000000
0.04
University Medical Center Utrecht (UMC Utrecht), Netherlands
1.000000
0.04
Center for Integrated Oncology Aachen Bonn Köln Düsseldorf (CIO), Germany
1.000000
0.04
Qilu Hospital of Shandong University, China
1.000000
0.04
Japanese Red Cross Aichi Medical Center Nagoya First Hospital, Japan
1.000000
0.04
Novartis Pharmaceuticals Corporation, United States of America (USA)
1.000000
0.04
All India Institute of Medical Sciences - Rishikesh (AIIMS Rishikesh), India
1.000000
0.04
Hospital Sultanah Aminah (HSA), Malaysia
1.000000
0.04
AZ Delta, Belgium
1.000000
0.04
Imperial College London (ICL), United Kingdom (UK)
1.000000
0.04
Yamanashi Prefectural Central Hospital, Japan
1.000000
0.04
Faculty of Medicine Siriraj Hospital, MU, Thailand
1.000000
0.04
University Hospital Brno, Czech Republic
1.000000
0.04
Institute of Hematology and Blood Diseases Hospital, CAMS & PUMC, China
1.000000
0.04
Massachusetts General Hospital (MGH), United States of America (USA)
1.000000
0.04
Taipei Chang Gung Memorial Hospital, Taiwan
0.666667
0.03
University of Oslo (UiO), Norway
0.500000
0.02
CHU Henri-Mondor, France
0.500000
0.02
Paris-Est Créteil University (UPEC), France
0.500000
0.02
Østfold Hospital, Norway
0.500000
0.02
Jena University Hospital (UKJ), FSU, Germany
0.500000
0.02
Catholic Hematology Hospital, South Korea
0.500000
0.02
Seoul St. Mary's Hospital, South Korea
0.500000
0.02
MVZ Labor PD Dr. Volkmann und Kollegen, Germany
0.500000
0.02
University of Trieste (UNITS), Italy
0.500000
0.02
Azienda sanitaria universitaria Giuliano Isontina (ASU GI), Italy
0.500000
0.02
Chang Gung University (CGU), Taiwan
0.333333
0.01